Deciphering the molecular landscape in chronic lymphocytic leukemia: time frame of disease evolution
about
Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia.Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutationsThe long-term outcome of patients in the LRF CLL4 trial: the effect of salvage treatment and biological markers in those surviving 10 years.Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors.Prognostic indices in chronic lymphocytic leukaemia: where do we stand how do we proceed?Chronic lymphocytic leukemia: Time to go past genomics?Mutations in NOTCH1 PEST-domain orchestrate CCL19-driven homing of Chronic Lymphocytic Leukemia cells by modulating the tumor suppressor gene DUSP22.Antigen receptor stereotypy in chronic lymphocytic leukemia.Chronic lymphocytic leukemia and small lymphocytic lymphoma: two faces of the same disease.EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia.Telomere length analysis in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Binet A.Next-generation sequencing in chronic lymphocytic leukemia: recent findings and new horizons.Innovation in the prognostication of chronic lymphocytic leukemia: how far beyond TP53 gene analysis can we go?Management of high risk chronic lymphocytic leukaemia (CLL) patients in Australia.STAT3 mediates C6-ceramide-induced cell death in chronic lymphocytic leukemiaDesign and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemiaCanadian evidence-based guideline for the first-line treatment of chronic lymphocytic leukemia
P2860
Q27853333-D3C77B9E-2854-4F72-986F-5AD74D67B6EAQ36622188-9BD14AEA-EB98-469F-9C55-49ED03909FA0Q36800105-0DF517F0-D812-4142-8AE6-ED8DCD8CA08EQ37140491-240B5CAF-7F5C-41B4-BA15-6E83CFCD0191Q38680890-E4227DE4-EA3F-4450-93F4-81D8089A9372Q38708220-459A29C8-B92B-4F86-8276-DDCA5CB2B2A9Q38724344-EAE1D46A-CDCA-431A-8091-B7F7CDD84CE5Q38998146-B5423CED-A351-4912-AF73-3835DC243F50Q39034465-72AEC740-896A-4CF1-B054-3D5C8B6543FDQ40455172-8A4630B3-B1E6-40E2-8AA1-C7CA67558580Q42250056-E832D30B-DE7A-4634-ACA3-4B0BE81835A0Q42378526-3FAAACA0-CB0E-4261-A3AA-F856741516D0Q42923891-01D790B5-5505-409F-8C08-E511069BBB2FQ49692075-70B25E33-A333-463D-AAE8-D370A89C16EBQ56481251-D447203B-B7E1-46A4-9C38-12888724D1BFQ57170496-61E00C74-B9E9-4D8B-AEB3-1DDAAA33A133Q59126180-E6B51E92-D80E-4512-AE82-7C40CA027A02
P2860
Deciphering the molecular landscape in chronic lymphocytic leukemia: time frame of disease evolution
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Deciphering the molecular land ...... ime frame of disease evolution
@ast
Deciphering the molecular land ...... ime frame of disease evolution
@en
Deciphering the molecular land ...... ime frame of disease evolution
@nl
type
label
Deciphering the molecular land ...... ime frame of disease evolution
@ast
Deciphering the molecular land ...... ime frame of disease evolution
@en
Deciphering the molecular land ...... ime frame of disease evolution
@nl
prefLabel
Deciphering the molecular land ...... ime frame of disease evolution
@ast
Deciphering the molecular land ...... ime frame of disease evolution
@en
Deciphering the molecular land ...... ime frame of disease evolution
@nl
P2860
P1433
P1476
Deciphering the molecular land ...... ime frame of disease evolution
@en
P2093
L.-A. Sutton
R. Rosenquist
P2860
P356
10.3324/HAEMATOL.2014.115923
P407
P577
2015-01-01T00:00:00Z